Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

373.86

339.73

34.13

10.05%

Other Operating Income

0.00

Total Operating income

373.86

339.73

34.13

10.05%

Raw Material Cost

84.47

151.00

-66.53

-44.06%

Purchase of Finished goods

13.32

16.02

-2.70

-16.85%

(Increase) / Decrease In Stocks

12.03

6.18

5.85

94.66%

Employee Cost

61.81

32.70

29.11

89.02%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

91.77

58.38

33.39

57.19%

Total Expenditure (Excl Depreciation)

263.40

264.28

-0.88

-0.33%

Operating Profit (PBDIT) excl Other Income

110.46

75.45

35.01

46.40%

Other Income

4.36

15.86

-11.50

-72.51%

Operating Profit (PBDIT)

114.82

91.31

23.51

25.75%

Interest

0.10

0.36

-0.26

-72.22%

Exceptional Items

0.00

Gross Profit (PBDT)

114.72

90.95

23.77

26.14%

Depreciation

5.90

8.83

-2.93

-33.18%

Profit Before Tax

108.82

82.12

26.70

32.51%

Tax

31.23

21.20

10.03

47.31%

Provisions and contingencies

0.00

Profit After Tax

77.59

60.91

16.68

27.38%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

77.59

60.91

16.68

27.38%

Equity Capital

16.60

45.32

-28.72

-63.37%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

46.74

1.34

45.40

3,388.06%

Diluted Earnings per share

46.74

1.34

45.40

3,388.06%

Operating Profit Margin (Excl OI)

29.55%

22.21%

0.00

7.34%

Gross Profit Margin

30.69%

26.77%

0.00

3.92%

PAT Margin

20.75%

17.93%

0.00

2.82%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 373.86 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 15.06% vs -4.08% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 77.59 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -12.37% vs 33.79% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 110.46 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -8.16% vs 33.13% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Quarterly - Interest

Interest 0.10 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 0.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 29.55%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024